Biogen to Present at the Goldman Sachs Alzheimer’s Symposium

CAMBRIDGE, Mass.--()--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Goldman Sachs Alzheimer’s Symposium. The webcast will be live on Monday, April 11, 2016 at 12:20p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available for 14 days following the presentation.

About Biogen

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.

Contacts

Biogen
Karen Jewell, 781-464-2442
Investor Relations

Recent Stories

RSS feed for Biogen Inc.

Release Summary

Biogen to Present at the Goldman Sachs Alzheimer’s Symposium

Biogen Inc.